100 likes | 107 Vues
Chapter 70. Weight Management. Drug Overview. Anorexiants Mixed neurotransmitter reuptake inhibitor Sympathomimetic Lipase Inhibitors Indications. Mechanism of Action. sibutramine phentermine orlistat. Treatment Principles. Standardized Guidelines
E N D
Chapter 70 Weight Management
Drug Overview • Anorexiants • Mixed neurotransmitter reuptake inhibitor • Sympathomimetic • Lipase Inhibitors • Indications
Mechanism of Action • sibutramine • phentermine • orlistat
Treatment Principles • Standardized Guidelines • U.S. Preventive Services Task Force: Guidelines for screening for obesity in adults, revised 2003. • National Heart, Lung, and Blood Institute at NIH: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults, 2003
Treatment Principles • Evidence-Based Recommendations • Cardinal Points of Treatment • Nonpharmacologic Treatment • Diet • Exercise • Behavior • Surgery
Treatment Principles • Pharmacologic Treatment • NHLBI guidelines • Role of diet and exercise • sibutramine • phentermine • orlistat • Herbal and OTC preparations • Evaluation of patients who have taken dexfenfluramine or fenfluramine
Treatment Principles • How to Monitor • Patient Variables • Geriatrics • Pediatrics • Pregnancy and lactation • Patient Education
Anorexiants • sibutramine (Meridia) • Contraindications • Warnings • Precautions • Pharmacokinetics • Adverse effects • Drug interactions • Dosage and administration
Anorexiants • phentermine (Fastin, Ionamin) • Contraindications • Warnings • Precautions • Adverse effects • Dosage and administration
Lipase Inhibitors • orlistat (Xenical, Alli [OTC]) • Contraindications • Warnings • Precautions • Overdosage • Dosage and administration